Introduction
Semax and Selank are two prominent neuropeptides, both developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. While they share a common origin in research and structural similarities (both incorporate the Pro-Gly-Pro stabilizing tripeptide), they derive from different parent molecules and exhibit distinct neurological profiles. This comparison guides researchers in selecting the appropriate peptide for their neuroscience investigations.
What is Semax?
Semax is a heptapeptide (7 amino acids) derived from ACTH fragment 4-10 with a Pro-Gly-Pro C-terminal extension. It primarily upregulates BDNF and NGF, interacts with melanocortin receptors (MC3R, MC4R), and modulates dopaminergic and serotonergic neurotransmission. Its research profile emphasizes cognitive enhancement and neuroprotection.
What is Selank?
Selank is a heptapeptide derived from the endogenous immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg) with a Pro-Gly-Pro extension. It modulates GABAergic neurotransmission, influences serotonin metabolism, and regulates the expression of brain-derived neurotrophic factor. Its research profile emphasizes anxiolytic and immunomodulatory effects.
Key Differences
| Feature | Semax | Selank |
|---|---|---|
| Parent Molecule | ACTH 4-10 | Tuftsin (Thr-Lys-Pro-Arg) |
| Primary Profile | Nootropic / Neuroprotective | Anxiolytic / Immunomodulatory |
| Key Receptors | Melanocortin MC3R/MC4R | GABAergic system |
| BDNF Effect | Strong upregulation | Moderate upregulation |
| Dopamine Effect | Increases turnover | Minimal direct effect |
| Anxiolytic? | Mild | Prominent |
| Immune Effects | Moderate | Strong (tuftsin-derived) |
Research Applications Compared
Cognitive Research
Semax demonstrates stronger nootropic effects in cognitive research models, with consistent improvements in learning, memory formation, and attention tasks. Selank’s cognitive effects are more modest but significant in anxiety-related cognitive impairment models.
Anxiety and Stress Research
Selank is the preferred peptide for anxiety research due to its GABAergic modulation and consistent anxiolytic effects without sedation or dependence. Semax has milder anxiolytic properties secondary to its primary nootropic effects.
Neuroprotection Research
Semax has more extensive neuroprotection data, particularly in ischemic brain injury models where it has demonstrated reduced infarct volume and improved neurological outcomes. Selank’s neuroprotective effects are less characterized but suggest benefit through reduced neuroinflammation.
Immune Research
Selank’s derivation from tuftsin gives it stronger immunomodulatory properties. Research has shown effects on T-cell function, cytokine expression, and immune response regulation. Semax has immunomodulatory activity but it is secondary to its neurological effects.
Conclusion
Semax and Selank represent complementary approaches to neuropeptide research. Semax is optimal for cognitive enhancement and neuroprotection studies, while Selank is preferred for anxiety, stress, and neuroimmune research. Both peptides demonstrate the potential of rationally designed neuropeptides based on endogenous fragments.
All products are sold strictly for research purposes only. Not for human consumption.